Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Conditioned media from human amniotic fluid-derived stem cells helps skin heal and protects against aging from sun exposure.

Compounds from Polygonum multiflorum root, especially a new one, can boost hair growth more effectively than common treatments.

IL-1 alpha stops hair follicle growth and hair production.

1,25-(OH)2D3 helps hair grow by blocking certain harmful signals.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

Blocking IL-17 might help treat the hair loss condition Lichen planopilaris.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Targeting IL-17 could help treat pattern hair loss.

Higher IL-17A levels indicate more severe alopecia areata.

Human TMEM2 does not break down hyaluronan but helps control its metabolism.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Hair stiffness increased by 13.2% after caffeine treatment, validating the Stiffness-Angle Law as an effective measurement method.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

The meeting highlighted major advances in skin research, including new findings on skin microbes, genetic links to skin diseases, and improved treatments for various conditions.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.